乙酸-(2,2-二甲基丁酯) | 101870-43-3

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 乙酸-(2,2-二甲基丁酯)
• 英文名称: acetic acid-(2,2-dimethyl-butyl ester)
• 英文别名: Essigsaeure-(2,2-dimethyl-butylester)；2,2-Dimethylbutyl ethanoate；2,2-dimethylbutyl acetate
• CAS: 101870-43-3
• 化学式: C₈H₁₆O₂
• 分子量: 144.214
• InChiKey: NHYAVJHYAAAJFM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  10
• 可旋转键数：
  4
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2,2-二甲基丁酸 在 吡啶 、 lithium aluminium tetrahydride 、 乙醚 作用下， 生成 乙酸-(2,2-二甲基丁酯)
  参考文献：
  名称：

  The Synthesis of Branched Primary and Secondary Alkyl Acetates

  摘要：

  DOI：

  10.1021/ja01601a068

文献信息

• SUBSTITUTED IMIDAZOLES
  申请人：CHUBB NATHAN ANTHONY LOGAN

  公开号：US20070167506A1

  公开（公告）日：2007-07-19

  This invention relates to a range of alpha substituted 2-benzyl substituted imidazole compounds and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes for their synthesis and their use as parasiticides.

  本发明涉及一系列α取代的2-苄基取代咪唑化合物及其药用可接受盐和溶剂化合物，包括这些化合物的组合物、合成过程以及它们作为驱虫剂的用途。
• Benzamidine derivatives
  申请人：SANKYO COMPANY, LIMITED

  公开号：US20040248981A1

  公开（公告）日：2004-12-09

  Benzamidine derivatives of formula (I) or pharmaceutically acceptable salts thereof exhibit excellent inhibitory activity against factor Xa and are useful for treating or preventing blood coagulation disorders: 1 wherein R 1 represents a hydrogen atom, a halogen atom, an alkyl group or a hydroxyl group; R 2 represents a hydrogen atom, a halogen atom or an alkyl group, R 3 represents a hydrogen atom, an optionally substituted alkyl group, an aralkyl group, an optionally substituted alkanoyl group or an optionally substituted alkylsulfonyl group, R 4 and R 5 are the same as or different from each other and each represent a hydrogen atom, a halogen atom, an optionally substituted alkyl group, an alkoxy group, a carboxyl-group, an alkoxycarbonyl group or an optionally substituted carbamoyl group, and R 6 represents a substituted pyrrolidine group or substituted piperidine group.

  公式（I）中的苯甲酰胺衍生物或其药学上可接受的盐表现出优异的抑制因子Xa的活性，可用于治疗或预防血液凝固障碍：其中R1代表氢原子，卤原子，烷基或羟基；R2代表氢原子，卤原子或烷基，R3代表氢原子，可选取代的烷基，芳基烷基，可选取代的烷酰基或可选取代的烷基磺酰基，R4和R5相同或不同，每个代表氢原子，卤原子，可选取代的烷基，烷氧基，羧基，烷氧羰基或可选取代的氨基甲酰基，而R6代表取代的吡咯烷基或取代的哌嗪烷基。
• Thermoplastic resin composition
  申请人：JAPAN SYNTHETIC RUBBER CO., LTD.

  公开号：EP0409291A2

  公开（公告）日：1991-01-23

  A thermoplastic resin composition consisting essentially of (A) 5 to 99% by weight of a hydrogenated polymer which is a hydrogenation product of a polymer represented by general formula (I): or a mixture of the norbornene derivative and a monomer copolymerizable therewith to ring-opening polymerization and (B) 95 to 1% by weight of at least one member selected from the group consisting of (B-1) a rubbery polymer and (B-2) a thermoplastic resin. The thermoplastic resin composition has excellent impact resistance and ductility.

  一种热塑性树脂组合物，其主要成分为：(A) 5-99%（按重量计）的氢化聚合物，它是通式(I)所代表的聚合物的氢化产物： 或降冰片烯衍生物与可与之开环聚合的单体的混合物，以及 (B) 95-1%（按重量计）的至少一种选自(B-1)橡胶聚合物和(B-2)热塑性树脂的成员。热塑性树脂组合物具有优异的抗冲击性和延展性。
• BENZAMIDINE DERIVATIVES
  申请人：Sankyo Company, Limited

  公开号：EP1245564A1

  公开（公告）日：2002-10-02

  Benzamidine derivatives of formula (I) or pharmaceutically acceptable salts thereof exhibit excellent inhibitory activity against factor Xa and are useful for treating or preventing blood coagulation disorders: wherein R1 represents a hydrogen atom, a halogen atom, an alkyl group or a hydroxyl group; R2 represents a hydrogen atom, a halogen atom or an alkyl group, R3 represents a hydrogen atom, an optionally substituted alkyl group, an aralkyl group, an optionally substituted alkanoyl group or an optionally substituted alkylsulfonyl group, R4 and R5 are the same as or different from each other and each represent a hydrogen atom, a halogen atom, an optionally substituted alkyl group, an alkoxy group, a carboxyl group, an alkoxycarbonyl group or an optionally substituted carbamoyl group, and R6 represents a substituted pyrrolidine group or substituted piperidine group.

  式（I）的苯甲脒衍生物或其药学上可接受的盐类对 Xa 因子具有优异的抑制活性，可用于治疗或预防血液凝固紊乱： 其中 R1 代表氢原子、卤素原子、烷基或羟基；R2代表氢原子、卤素原子或烷基，R3代表氢原子、任选取代的烷基、芳烷基、任选取代的烷酰基或任选取代的烷磺酰基，R4和R5彼此相同或不同，各自代表氢原子、卤素原子、任选取代的烷基、烷氧基、羧基、烷氧羰基或任选取代的氨基甲酰基，R6代表取代的吡咯烷基或取代的哌啶基。
• INK COMPOSITION, INKJET RECORDING METHOD, PRINTED MATTER, AND HIGH-MOLECULAR-WEIGHT POLYMERIZATION INITIATOR
  申请人：Fujifilm Corporation

  公开号：EP2960303A1

  公开（公告）日：2015-12-30

  An ink composition contains (component A) a high-molecular-weight polymerization initiator having a weight-average molecular weight of equal to or greater than 1,000, (component B) a polymerizable compound, and (component C) a colorant, in which the component A has an acylphosphine oxide structure, and the acylphosphine oxide structure is linked to a main chain or a core of the component A on the side of an acyl group thereof.

  一种油墨组合物含有（成分 A）重量平均分子量等于或大于 1 000 的高分子量聚合引发剂、（成分 B）可聚合化合物和（成分 C）着色剂，其中成分 A 具有酰基氧化膦结构，酰基氧化膦结构在其酰基一侧与成分 A 的主链或核心相连。